The last international guidelines on the evaluation and management of primary
hyperparathyroidism (PHPT) were published in 2014. Research since that time has led to …

The conventional treatment of hypoparathyroidism (HypoPT) includes active vitamin D and
calcium. Despite normalization of calcium levels, the conventional treatment is associated …

This clinical practice guideline addresses the prevention, diagnosis, and management of
hypoparathyroidism (HypoPT) and provides evidence‐based recommendations. The …

Within the lifetimes of many of us, primary hyperparathyroid-ism (PHPT) has changed from a
rare disorder of calcium metabolism to one of the most common. Along with an increase in …

Purpose The identification of patients with chronic hypoparathyroidism who are adequately
(AC) or not adequately controlled (NAC) has clinical interest, since poor disease control is …

ABSTRACT The 2022 International Task Force guidelines for chronic hypoparathyroidism
will be published within several months in the Journal of Bone and Mineral Research. These …

Chronic hypoparathyroidism (HypoPT) is associated with significant morbidity and impaired
quality of life (QoL). The goals of management for chronic HypoPT include improvement in …

Primary hyperparathyroidism (pHPT) afflicts our aging population with an incidence
approaching 50 per 100 000 patient-years at a female: male ratio of~ 3: 1. Decisions …

Methods Literatures regarding to the epidemiology, genetics, risk factors, clinical
manifestations and therapies for hypoPT in Easten and Western countries, including China …

Hypoparathyroidism - StatPearls - NCBI Bookshelf US flag An official website of the United
States government Here's how you know NIH NLM Logo Access keys NCBI Homepage …